Plate Nº 67 · recorded November 16, 2026

Health & Medicine ResearchReported finding

High-Dose Flu Shot Linked to 22% Lower Alzheimer's Risk in Seniors

A high-dose flu vaccine was tied to up to 22% lower Alzheimer's risk over two years versus a standard shot, in a study of nearly 165,000 US adults aged 65 and older.

By Nathan Brooks3 min read697 words

In brief

  1. High-dose flu vaccine tied to up to 22% lower Alzheimer's risk over two years versus standard dose
  2. Study analyzed health data of nearly 165,000 US adults aged 65 and older, published in Neurology
  3. As of 2022, the CDC recommends high-dose flu vaccine (4x the antigen) for people over 65
  4. The protective association faded after about two years and did not prove causation
  5. Earlier 2022 research linked any flu vaccine to roughly 40% lower Alzheimer's risk among 1.9 million adults
A High-Dose Flu Vaccine Is Linked to Nearly 55% Lower Alzheimer's Risk
Plate Nº 67A High-Dose Flu Vaccine Is Linked to Nearly 55% Lower Alzheimer's Risk — fernandozhiminaicela / pixabay

A high-dose flu vaccine was linked to up to a 22 percent lower risk of developing Alzheimer's disease over two years, compared with a standard-dose shot, in a study of nearly 165,000 US adults aged 65 and older. Stack that on top of earlier findings for unvaccinated people, and the total difference approaches 55 percent lower Alzheimer's risk.

Researchers at the University of Texas Health Science Center at Houston published the findings in the journal Neurology. It's the first study to ask whether the high-dose flu vaccine is associated with a lower Alzheimer's risk than the standard version.

What did the study actually measure?

The team analyzed health records of nearly 165,000 adults aged 65 and older. Those who received a high-dose influenza vaccine had up to 22 percent lower risk of an Alzheimer's diagnosis over the following two years than those who got a standard shot. Combined with the group's earlier work comparing vaccinated and unvaccinated people, that adds up to nearly a 55 percent lower risk overall, according to UTHealth Houston.

Two details sharpened the picture:

  • Participants who received repeated annual high-dose vaccines kept their lower risk slightly longer than those who switched back to standard doses.
  • The association was even stronger among women than among men.

The study builds on 2022 research by some of the same scientists, which found that among nearly 1.9 million US adults aged 65 and older, any flu vaccine at all was linked to roughly a 40 percent lower Alzheimer's risk compared with no flu vaccine.

What is a high-dose flu vaccine?

It's a flu shot containing four times as much influenza antigen — the ingredient that trains the immune system — as a standard dose. The extra punch is designed to trigger a stronger immune response in older people, whose immune systems can be slowing down.

As of 2022, the US Centers for Disease Control and Prevention recommends the high-dose version for everyone over 65. Yet awareness lags, even among doctors. Study senior author Paul Schulz, a neurologist at UTHealth Houston, said he was baffled when a local public health department asked whether dosage made a difference in his vaccine research.

"We went through the findings, and they asked if there was a difference with different dosages; I was confused," Schulz said. "I was stunned that, as a physician, I didn't know a higher dose was offered."

Could the link be a coincidence?

Possibly, and the researchers say so plainly. Erin Abner, an epidemiologist at the University of Kentucky who was not involved in the study, told Neurology Today the findings support current vaccine recommendations for older adults. But she cautioned they don't prove causation.

The result could still be a "spurious association," Abner explained, "due to people who can and do get the high-dose vaccine being somehow different or healthier than people who get the standard-dose vaccine."

The study has other limits. The two-year window is short compared with Alzheimer's slow progression — dementia can take decades to become symptomatic, meaning many participants diagnosed in the study likely already had the underlying disease when they got their shots.

Is the vaccine preventing or delaying Alzheimer's?

Several analyses suggest delay, not prevention. When Schulz and colleagues removed all participants who had received any flu vaccine in the two years before their study shot, the association largely disappeared.

The timing also tells a story. After excluding people diagnosed with Alzheimer's within a month of vaccination, the protective association only became statistically significant eight months later. And for all participants, the link faded after about two years, when it was no longer statistically significant.

That pattern raises the possibility that the vaccines may be delaying the onset of dementia symptoms — perhaps by reducing inflammation — rather than stopping the underlying disease itself. Vaccines against shingles, RSV, pneumococcal disease, tetanus, and diphtheria have all been tied to reduced dementia risk, too.

How an annual shot fits into a disease that silently develops over decades remains an open question. Scientists, as Schulz's team puts it, are on the case.

via sciencealert.com (Source)

Filed under

  • alzheimer-s-disease
  • high-dose-flu-vaccine
  • influenza-vaccination
  • dementia-risk
  • older-adults
Share this article:

More from Nathan Brooks

Nathan Brooks

Show full bio

Market editor covering companies, deals and strategy in general science news at SciBeat.

385 articles

Nearby plates

« Previous article